Overview
Peter Habenberger practices in Dortmund, Germany. Mr. Habenberger is rated as an Advanced expert by MediFind in the treatment of NUT Carcinoma. His top areas of expertise are Chronic T-Cell Leukemia (CTCL), Prolymphocytic Leukemia, NUT Carcinoma, and Adult T-Cell Leukemia.
His clinical research consists of co-authoring 14 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of NUT Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic T-Cell Leukemia (CTCL)Mr. Habenberger isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- NUT CarcinomaMr. Habenberger isAdvanced. Learn about NUT Carcinoma.
- Prolymphocytic LeukemiaMr. Habenberger isAdvanced. Learn about Prolymphocytic Leukemia.
- Experienced
- Adult T-Cell LeukemiaMr. Habenberger isExperienced. Learn about Adult T-Cell Leukemia.
- Hospital-Acquired PneumoniaMr. Habenberger isExperienced. Learn about Hospital-Acquired Pneumonia.